A judge approved Friday a temporary restraining order to make sure medical evidence and records remain untouched pending investigation into a contaminated drug given to patients at Corpus Christi Medical Center hospitals.
The drug, administered intravenously, reportedly infected as many as 19 patients, and may have caused four deaths, though there has been no definitive word yet as to whether or not those deaths were caused by the contamination.
On Friday, Attorney Thomas J. Henry, who now represents those affected patients, spoke about the case.
"This is an ongoing investigation, and the first step is to make sure you restrain the product," Henry said. "The second step is to get the product identification information from patient files, and, of course, these are individuals who are coming to us making representations that they were in this hospital and a loved one or they themselves became ill, or they had a concern of their exposure to this particular product."
The drug in question is called calcium gluconate. It is a solution used to replace calcium in patients who lack enough of that element in their body. In this case, it was supplied by a pharmacy called Specialty Compounding, who are currently being investigated by the Food and Drug Administration.
All content © Copyright 2000 - 2013 WorldNow and KIII. All Rights Reserved.